APS pre-treatment also greatly suppressed the inflammatory response in lung tissue and inhibited NFκB signaling pathway by which immune cells produce inflammatory cytokines (Lu et al., 2008). Here, NFKB1 is linked to autoimmune polyendocrinopathy.